Detalles de la búsqueda
1.
Efficacy and safety of Once-Daily Vilanterol/Fluticasone furoate MDI in persistent asthma: Phase 3 OD-INHALE Study.
J Asthma
; : 1-9, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38488853
2.
A Multicentric, Prospective, Observational, Single-Arm Registry Study to Assess the Clinical Safety and Effectiveness of Thrombophob Ointment (Heparin Sodium + Benzyl Nicotinate) in Indian Patients With Thrombophlebitis.
Cureus
; 16(2): e54436, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38510884
3.
Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial.
Cureus
; 16(5): e60162, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38868264
4.
Long-term Persistence of Immunogenicity After Primary Vaccination and Response to Booster Vaccination With Typhoid Conjugate Vaccine: Results of a Phase IV Extension Study.
Indian Pediatr
; 59(5): 388-392, 2022 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348124
5.
Choline Fenofibrate Delayed Release Capsules Versus Conventional Fenofibrate Tablets for Dyslipidemia: A Randomized, Non-Inferiority Trial.
J Assoc Physicians India
; 63(8): 20-6, 2015 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27604432
6.
Immunogenicity and Safety of Typhoid Conjugate Vaccine in Healthy Indian Subjects: A Randomized, Active-controlled, Comparative Clinical Trial.
Indian Pediatr
; 57(7): 625-630, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727938
7.
Long-term Persistence of Immunogenicity After Primary Vaccination and Response to Booster Vaccination With Typhoid Conjugate Vaccine: Results of a Phase IV Extension Study
Indian Pediatr
; 2022 May; 59(5): 388-392
Artículo
| IMSEAR | ID: sea-225332
8.
Resultados
1 -
8
de 8
1
Próxima >
>>